Daily use of diversified segmental defocus optimization (DSDO) spectacle lenses delays the onset of myopia among children, ...

Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure increasing danger of macular degeneration.

A new study from Moorfields Eye Hospital and University College London has raised a possible concern for people taking a ...

JAMA Ophthalmology (formerly Archives of Ophthalmology) is a monthly professional medical journal published by the American Medical Association. Archives of Ophthalmology publishes peer-reviewed ...

Inconsistent fees paid to doctors and facilities show the disadvantage independent clinicians face in the market.

BUFFALO, N.Y. — A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a direct causal link with the drugs has not been established.

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Patients undergoing retinal detachment (RD) repair with concomitant cannabis use have a lower risk for subsequent ...

The connection stayed even in people who had normal pressure in their eyes, which is unusual. Normally, glaucoma is linked to ...

A new study in JAMA Ophthalmology highlights the importance for people with type 2 diabetes who take GLP-1 medicines to contact their health care provider immediately if they experience any vision ...

In patients with diabetes, semaglutide use was associated with an increased risk for nonarteritic anterior ischemic optic neuropathy, according to a study published in JAMA Ophthalmology.

Patients undergoing retinal detachment (RD) repair with concomitant cannabis use have a lower risk of subsequent ...